Real-world study: RSV vaccine 78% to 80% effective against infection, severe illness in older US veterans- Mary Van Beusekom, MS
The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory virus season against infection, emergency department/urgent care (ED/UC) visits, and hospitalization was 78%, 79%, and 80%, respectively. The…








